HQ Science Ltd.
HQ Science Ltd. is a UK-based British-German MedTech company specializing in decentralized, point-of-care personalized molecular diagnostics through its flagship product, the Tachyon platform. Tachyon integrates advanced long-read nanopore sequencing with sophisticated AI-driven bioinformatics to deliver rapid, precise, and cost-effective genetic analysis directly from clinical samples. The device significantly reduces diagnostic turnaround times from weeks to under 24 hours, enabling real-time, actionable insights in various medical fields including oncology, radiation preparedness, infectious disease management, and sepsis care. Tachyon's versatility, high throughput, and cost-efficiency position HQ Science at the forefront of precision medicine, supporting healthcare providers with decentralized diagnostics that improve clinical outcomes and emergency response capabilities. The company is led by founder and CEO Stanislav Polozov, with a strong team of scientists and engineers, and collaborates with global health agencies such as the UK Health Security Agency (UKHSA).
HQ Science Ltd.
HQ Science Ltd. is a UK-based British-German MedTech company specializing in decentralized, point-of-care personalized molecular diagnostics through its flagship product, the Tachyon platform. Tachyon integrates advanced long-read nanopore sequencing with sophisticated AI-driven bioinformatics to deliver rapid, precise, and cost-effective genetic analysis directly from clinical samples. The device significantly reduces diagnostic turnaround times from weeks to under 24 hours, enabling real-time, actionable insights in various medical fields including oncology, radiation preparedness, infectious disease management, and sepsis care. Tachyon's versatility, high throughput, and cost-efficiency position HQ Science at the forefront of precision medicine, supporting healthcare providers with decentralized diagnostics that improve clinical outcomes and emergency response capabilities. The company is led by founder and CEO Stanislav Polozov, with a strong team of scientists and engineers, and collaborates with global health agencies such as the UK Health Security Agency (UKHSA).